Express Scripts (ESRX, Financial) recently acquired eviCore Healthcare, an industry leader in evidence-based medical benefit management services. EviCore helps manage medical benefits for 100 million people, and Express Scripts expects the acquisition to be accretive to adjusted diluted earnings per share in 2018, which they now estimate in the range of $7.67 to $7.87. At a P/E of 12 times 2018 the stock seems very cheap.
From Jeff Auxier (Trades, Portfolio)'s fourth quarter 2018 shareholder letter.
Also check out:
